Melih Simsek

16PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 26, 2026
Chemotherapy Response Score and Survival Outcomes After Neoadjuvant Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma: A Multicenter Retrospective Study.

|Sep 03, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Ogur Karhan, Serdar İleri, Zuhat Urakçı

|Aug 17, 2025
New targets and strategies in treatment of metastatic gastric cancer.

Melih Simsek, Haci Mehmet Turk

|Jul 30, 2025
Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors.

Zehra Sucuoğlu İşleyen, Harun Muğlu, Zeynep Alaca Topçu

|May 28, 2025
Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study.

Furkan Ceylan, Selin Aktürk Esen, Olçun Ümit Ünal

|Mar 27, 2025
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group.

Nadiye Sever, Fatih Şimşek, İlknur Deliktaş Onur

Pageof 3

Frequent Collaborators

6 joint publications

Hacı Mehmet Türk

5 joint publications

Zehra Sucuoglu Isleyen

4 joint publications

Ayse Irem Yasin

4 joint publications

Mesut Seker